Akrivis Technologies LLC
Versatile, ultrasensitive immunoassays
This article was originally published in Start Up
Akrivis Technologies has built its business around an immunoassay detection platform that has the potential to deliver much higher sensitivity than traditional techniques. The company is positioning its Z-TECT technology for use in research, diagnostics development, medical imaging and, potentially, drug delivery.